Cytosorbents (CTSO) EBITDA Margin (2011 - 2026)
Cytosorbents' (CTSO) quarterly EBITDA Margin came in at 34.34% in Q1 2026, up 1021.0% YoY from 3.06% in Q1 2025, and up 27.68% on a QoQ basis from 47.49% in Q4 2025.
Cytosorbents (CTSO) EBITDA Margin (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 16 years of EBITDA Margin data on file, last reported at 34.34% in Q1 2026.
- Quarterly EBITDA Margin rose 1021.0% year-over-year to 34.34% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 37.38% (up 700.0% YoY) and the FY2025 annual result came in at 39.79%, up 643.0% from the prior year.
- EBITDA Margin climbed to 34.34% in Q1 2026, from 47.49% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 30.17% in Q3 2025 to a low of 111.17% in Q3 2022.
- A 5-year average of 64.2% and a median of 56.08% in 2024 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin plunged 6273 bps — and 2024, when it soared 7144 bps.
- Tracing CTSO's EBITDA Margin over 5 years: stood at 67.69% in 2022, then sank by 60 bps to 108.54% in 2023, then jumped by 66 bps to 37.1% in 2024, then fell by 28 bps to 47.49% in 2025, then gained by 28 bps to 34.34% in 2026.
- The last three EBITDA Margin figures came in at 34.34% (Q1 2026), 47.49% (Q4 2025), and 30.17% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 19.15% |
| 10 | Cytosorbents | 20.86 Mn | 16.45 Mn | 7.05 Mn | -27.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.39% |
| Mar 31, 2026 | -34.34% |
| Dec 31, 2025 | -47.49% |
| Sep 30, 2025 | -30.17% |
| Jun 30, 2025 | -37.59% |
| Mar 31, 2025 | -44.55% |
| Dec 31, 2024 | -37.10% |
| Sep 30, 2024 | -56.08% |
| Jun 30, 2024 | -40.38% |
| Mar 31, 2024 | -51.80% |
| Dec 31, 2023 | -108.54% |
| Sep 30, 2023 | -83.42% |
| Jun 30, 2023 | -69.62% |
| Mar 31, 2023 | -83.51% |
| Dec 31, 2022 | -67.69% |
| Sep 30, 2022 | -111.17% |
| Jun 30, 2022 | -98.37% |
| Mar 31, 2022 | -89.64% |
| Dec 31, 2021 | -88.68% |
| Sep 30, 2021 | -55.39% |